Revolver Beer and Spirits, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY, TSX: TLRY), announced on July 23, 2026, its expansion from craft beer into the spirits market with the launch of the Blood & Honey lineup. The move extends the brand’s flagship beer profile—characterized by blood orange and honey flavors—into three new categories: Whiskey, Gin, and Vodka. This strategic category extension aims to capture modern consumer preferences for bold, versatile spirits that bridge the gap between rugged authenticity and refined taste, leveraging the established equity of the Texas-born beer brand.

The launch marks a significant diversification for Revolver, which has historically been known for its craft beer offerings. By translating the sensory profile of its best-selling beer into distilled spirits, the company seeks to deepen its engagement with existing consumers while attracting new demographics interested in premium, flavor-forward spirits. The products are crafted using raw, unfiltered Texas honey sourced from Burleson’s Honey in Waxahachie, Texas, reinforcing the brand’s regional identity and commitment to local ingredients.

Product Portfolio and Pricing

The Blood & Honey spirits line consists of three distinct products, each bottled at 80 proof (40% ABV). The lineup is designed for sipping, mixing, and cocktail creation, offering a consistent flavor narrative across different spirit bases.

Blood & Honey Whiskey is built on a foundation of rich grains with warm citrus undertones and a touch of honeyed sweetness. It features bright blood orange, gentle oak, smooth honey, soft vanilla, and a hint of clove, leading to a clean finish with a burst of blood orange zest. Blood & Honey Gin offers a crisp take on the classic spirit, blending curated botanicals with classic juniper, blood orange, citrus zest, and creamy honey for a smooth palate and refreshing finish. Blood & Honey Vodka is distilled for clarity with a hint of Blood & Honey essence, delivering vibrant blood orange zest, fresh juice, light honey, and delicate wildflowers, resulting in a soft finish with subtle vanilla notes.

Strategic Context

Ralph Huellemann, Texas State Sales Manager for Revolver Spirits, emphasized the strategic intent behind the launch. "Revolver has always stood for bold Texas flavor, and Revolver Blood & Honey Spirits bring the iconic Texas Blood & Honey beer into a new category with real energy and originality," Huellemann said. He noted that the lineup is built to stand out on shelves and behind bars, capitalizing on a powerful opportunity to offer consumers distinctive spirits rooted in Texas and inspired by an iconic beer.

The expansion aligns with Tilray Brands’ broader mission to operate as a leading global lifestyle and consumer packaged goods company. Tilray’s platform supports over 40 brands in more than 20 countries, spanning cannabis, beverage, wellness, and entertainment. By extending Revolver into spirits, Tilray leverages its existing distribution networks and brand expertise to drive growth in the competitive U.S. spirits market.

Availability

Revolver Blood & Honey Spirits will be available exclusively in Texas beginning July 23, 2026. The limited geographic rollout allows the company to test market reception and refine its go-to-market strategy before potential broader expansion. Consumers can find more information about the products and availability at DrinkRevolver.com.

What the Numbers Show

The pricing structure of the Blood & Honey lineup positions the products competitively within the premium craft spirits segment. The Whiskey at $29.99 represents the premium tier of the launch, likely targeting sippers and collectors who value complexity and origin stories. The Gin at $23.99 and Vodka at $19.99 are priced to encourage trial and mixability, appealing to younger demographics and bartenders seeking unique base spirits for cocktails. This tiered pricing strategy suggests a focus on volume growth through accessible entry points (Vodka) while maintaining margin potential through the premium Whiskey offering. The exclusive use of local Texas honey serves as both a cost component and a marketing differentiator, potentially justifying the premium positioning against national competitors.

TD Cowen analyst Robert Moskow has maintained a Buy rating on Tilray Brands while lowering the price target to $5 from $7. The revised target indicates a shift in the firm's valuation expectations for the cannabis company's stock.

Rating and Price Target Adjustment

The decision to retain the Buy rating suggests continued confidence in Tilray Brands' long-term prospects despite the reduced price objective. The new target of $5 represents a decrease from the previous estimate of $7.

The adjustment comes as market conditions and company performance metrics are reassessed by the financial institution.